238 related articles for article (PubMed ID: 34432892)
1. Sodium glucose co-transporter-2 inhibitor-induced diabetic ketoacidosis following tooth extraction: improving awareness among dental practitioners.
Yap SD; Hamblin PS; Bach L; Ekinci E; Wong R
Aust Dent J; 2021 Dec; 66(4):444-447. PubMed ID: 34432892
[TBL] [Abstract][Full Text] [Related]
2. SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.
He Z; Lam K; Zhao W; Yang S; Li Y; Mo J; Gao S; Liang D; Qiu K; Huang M; Wu J
Acta Diabetol; 2023 Mar; 60(3):401-411. PubMed ID: 36576563
[TBL] [Abstract][Full Text] [Related]
3. Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment.
Sampani E; Sarafidis P; Papagianni A
Expert Opin Drug Saf; 2020 Jun; 19(6):673-682. PubMed ID: 32521174
[TBL] [Abstract][Full Text] [Related]
4. Predisposing factors for the development of diabetic ketoacidosis with lower than anticipated glucose levels in type 2 diabetes patients on SGLT2-inhibitors: a review.
Bamgboye AO; Oni IO; Collier A
Eur J Clin Pharmacol; 2021 May; 77(5):651-657. PubMed ID: 33244632
[TBL] [Abstract][Full Text] [Related]
5. A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care.
Taverner S; Eng C; Watson R; George S; Edwards A; Williams DM; Stephens JW
Diabetes Metab Syndr; 2022 Dec; 16(12):102658. PubMed ID: 36371968
[TBL] [Abstract][Full Text] [Related]
6. Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes Mellitus Receiving Oral Therapy.
Dull RB; Spangler ML; Knezevich EL; Lau BM
J Pharm Pract; 2019 Apr; 32(2):240-243. PubMed ID: 29241389
[TBL] [Abstract][Full Text] [Related]
7. Postoperative euglycaemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the literature.
Chacko B; Whitley M; Beckmann U; Murray K; Rowley M
Anaesth Intensive Care; 2018 Mar; 46(2):215-219. PubMed ID: 29519226
[TBL] [Abstract][Full Text] [Related]
8. The catabolic triad: case report of fasting, major cardiac surgery and sodium-glucose co-transporter 2 inhibitors leading to perioperative euglycaemic ketoacidosis.
Smyth CC; Collins M; McCarthy J; Galvin S
Interact Cardiovasc Thorac Surg; 2021 Aug; 33(3):494-495. PubMed ID: 33961026
[TBL] [Abstract][Full Text] [Related]
9. Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.
Sampani E; Sarafidis P; Dimitriadis C; Kasimatis E; Daikidou D; Bantis K; Papanikolaou A; Papagianni A
BMC Nephrol; 2020 Jul; 21(1):276. PubMed ID: 32669085
[TBL] [Abstract][Full Text] [Related]
10. SGLT-2 inhibitors associated euglycemic and hyperglycemic DKA in a multicentric cohort.
Ata F; Yousaf Z; Khan AA; Razok A; Akram J; Ali EAH; Abdalhadi A; Ibrahim DA; Al Mohanadi DHSH; Danjuma MI
Sci Rep; 2021 May; 11(1):10293. PubMed ID: 33986421
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year period.
Menghoum N; Oriot P; Hermans MP
Diabetes Metab Syndr; 2021; 15(6):102275. PubMed ID: 34562870
[TBL] [Abstract][Full Text] [Related]
12. Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors.
Isaacs M; Tonks KT; Greenfield JR
Intern Med J; 2017 Jun; 47(6):701-704. PubMed ID: 28580740
[TBL] [Abstract][Full Text] [Related]
13. Sodium-Glucose Co-transporter-2 Inhibitors Induced Diabetic Ketoacidosis in Patients Undergoing Bariatric Surgery: a Systematic Review of Case Reports and Case Series.
Gokhare Viswanath N; Sharma M; Bandlamudi N; Idris I; Singhal R; Mahawar K; Madhok B
Obes Surg; 2023 Jan; 33(1):339-344. PubMed ID: 36418772
[TBL] [Abstract][Full Text] [Related]
14. [Severe SGLT-2 inhibitor-induced euglycemic ketoacidosis-a rare but serious complication].
Rotsel E; Pietsch U
Anaesthesist; 2020 Jan; 69(1):49-51. PubMed ID: 31807797
[TBL] [Abstract][Full Text] [Related]
15. Sodium-glucose cotransport-2 inhibitor induced ketoacidosis following coronary artery bypass surgery: implications for management.
McCann M; O'Brien A; Larbalestier R; Davis T
Intern Med J; 2022 May; 52(5):876-879. PubMed ID: 35538006
[TBL] [Abstract][Full Text] [Related]
16. Perioperative implications of sodium-glucose cotransporter-2 inhibitors: a case series of euglycemic diabetic ketoacidosis in three patients after cardiac surgery.
Lau A; Bruce S; Wang E; Ree R; Rondi K; Chau A
Can J Anaesth; 2018 Feb; 65(2):188-193. PubMed ID: 29168157
[TBL] [Abstract][Full Text] [Related]
17. SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Burke KR; Schumacher CA; Harpe SE
Pharmacotherapy; 2017 Feb; 37(2):187-194. PubMed ID: 27931088
[TBL] [Abstract][Full Text] [Related]
18. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
[TBL] [Abstract][Full Text] [Related]
19. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors.
Fleming N; Hamblin PS; Story D; Ekinci EI
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32302001
[TBL] [Abstract][Full Text] [Related]
20. Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Liu J; Li L; Li S; Wang Y; Qin X; Deng K; Liu Y; Zou K; Sun X
Diabetes Obes Metab; 2020 Sep; 22(9):1619-1627. PubMed ID: 32364674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]